Hydrocortisone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 29 USDMF, 14 CEP/COS, 6 JDMF, 5 EU WC, 10 KDMF, 39 NDC API, 1 VMF, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

381 FDF Dossiers, 227 FDA Orange Book, 83 Europe, 13 Canada, 6 Australia, 27 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 8 SPI Pharma, 2 Seqens, 16 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 13 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 5 Pfanstiehl, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 3 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Topical, 76 Fillers, Diluents & Binders, 57 Solubilizers, 57 Thickeners and Stabilizers, 44 Parenteral, 40 Direct Compression, 30 Coating Systems & Additives, 29 Disintegrants & Superdisintegrants, 29 Lubricants & Glidants, 28 Granulation, 27 Emulsifying Agents, 24 Controlled & Modified Release, 20 Co-Processed Excipients, 20 Film Formers & Plasticizers, 20 Surfactant & Foaming Agents, 18 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Rheology Modifiers, 5 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 46 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 91 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

28 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 3 JP, 5 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22436 / DOSAGE - CREAM;TOPICAL - 5%;1%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ACYCLOVIR(UNII: X4HES1O11F) (ACYCLOVIR - UNII:X4HES1O11F)	ACYCLOVIR	50mg in 1
HYDROCORTISONE(UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ)	HYDROCORTISONE	10mg in 1

Inactive Ingredients

Ingredient Name	Bausch Health US LLC
cetostearyl alcohol(2DMT128M1S)
citric acid monohydrate(2968PHW8QP)
HYDROCHLORIC ACID(QTT17582CB)
isopropyl myristate(0RE8K4LNJS)
mineral oil(T5L8T28FGP)
petrolatum(4T6H12BN9U)
Poloxamer 188(LQA7B6G8JG)
propylene glycol(6DC9Q167V3)
sodium hydroxide(55X04QC32I)
sodium lauryl sulfate(368GB5141J)
water(059QF0KO0R)

Drug Product Composition: Hydrocortisone

Hydrocortisone

Hydrocortisone

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers

29 USDMF

14 CEP/COS

6 JDMF

5 EU WC

10 KDMF

39 NDC API

1 VMF

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

381 FDF Dossiers

227 FDA Orange Book

83 Europe

13 Canada

6 Australia

27 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

CREAM;TOPICAL - 5%;1%

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

TABLET;ORAL - 10MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc

8 SPI Pharma

2 Seqens

16 DKSH

2 Jai Radhe Sales

1 Pharm-RX Chemical

7 Faran Shimi Pharmaceutical

13 Gangwal Healthcare

24 Nanjing Well Pharmaceutical

5 Pfanstiehl

22 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

42 BASF

3 BioSpectra

1 Clariant

15 Corel Pharma Chem

7 DFE Pharma

6 Finar

16 Gangwal Chemicals

2 Hayashibara

3 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

31 Kerry

9 Lubrizol Life Science Health

17 Microlex e.U

3 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

33 Roquette

21 Seppic

2 Shandong Focus Biotechnology Co., Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 Valens Pharmachem

5 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons